Quick Takeaways
- Commander Aggregator, LP filed SCHEDULE 13D/A for Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX).
- Disclosed ownership: 4.5%.
- Date of event: 14 Aug 2025.
Commander Aggregator, LP - 14 Aug 2025 SCHEDULE 13D/A Report for Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX)
- Filing Manager
- Commander Aggregator, LP
- Reporting Manager
- Commander Aggregator, LP
- Symbol
- CMPX
- Shares outstanding
- 173,070,000 shares
- Disclosed Ownership
- 7,788,150 shares
- Ownership
- 4.5%
- Form type
- SCHEDULE 13D/A
- Filing time
- 18 Aug 2025, 18:35:02 UTC
- Date of event
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Commander Aggregator, LP disclosed 4.5% ownership in Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX) on 14 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Aug 2025, 18:35.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Commander Aggregator, LP | 4.5% | 7,788,150 | 0 | 7,788,150 | /s/ James P. Boylan | James P. Boylan / Chief Executive Officer | 0001953093 |
| Enavate Sciences, LP | 4.5% | 7,788,150 | 0 | 7,788,150 | /s/ James P. Boylan | James P. Boylan / Chief Executive Officer | 0001953098 |
| Enavate Sciences GP, LLC | 4.5% | 7,788,150 | 0 | 7,788,150 | /s/ James P. Boylan | James P. Boylan / Chief Executive Officer | 0001953107 |
| Enavate Sciences Holdings, LLC | 4.5% | 7,788,150 | 0 | 7,788,150 | /s/ James P. Boylan | James P. Boylan / Chief Executive Officer |